Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Helei Hou,* Kang Qin,* Yu Liang, Chuantao Zhang, Dong Liu, Haiping Jiang, Kewei Liu, Jingjuan Zhu, Hongying Lv, Tianjun Li, Xiaochun ZhangDepartment of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, People’s Republic of China*These authors cont...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Hou H, Qin K, Liang Y, Zhang C, Liu D, Jiang H, Liu K, Zhu J, Lv H, Li T, Zhang X
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2019-06-01
Serie:Cancer Management and Research
Ämnen:
TP53
Epidermal growth factor receptor
Tyrosine kinase inhibitors
Non-small-cell lung cancer
Mutation
Exon
Länkar:https://www.dovepress.com/concurrent-tp53-mutations-predict-poor-outcomes-of-egfr-tki-treatments-peer-reviewed-article-CMAR
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk